Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimecrolimus Cream 1% in Adult Perioral Dermatitis
NCT00232115Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Pimecrolimus vehicle + topical corticosteroid in perioral dermatitis (2 arms), sponsored by Novartis. Primary endpoint: Reduction of the Perioral Dermatitis Severity Index. Started Sep 2005; status: completed.
02
Drugs
Pimecrolimus vehicle + topical corticosteroid
03
Conditions
perioral dermatitis
Beyond the preview
Go deeper on NCT00232115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00232115.